Cantor Fitzgerald Reiterates Overweight Rating for UnitedHealth Group Inc (UNH)

UnitedHealth Group Inc (NYSE:UNH)‘s stock had its “overweight” rating restated by stock analysts at Cantor Fitzgerald in a research report issued on Saturday, April 22nd. They currently have a $205.00 target price on the healthcare conglomerate’s stock, up from their previous target price of $200.00. Cantor Fitzgerald’s price objective indicates a potential upside of 18.78% from the company’s current price.

A number of other analysts have also commented on UNH. Vetr raised shares of UnitedHealth Group from a “buy” rating to a “strong-buy” rating and set a $189.00 price objective for the company in a research note on Wednesday, December 28th. Piper Jaffray Companies began coverage on shares of UnitedHealth Group in a research note on Tuesday, January 3rd. They set an “overweight” rating and a $188.00 price objective for the company. Barclays PLC reissued a “buy” rating and issued a $187.00 price target on shares of UnitedHealth Group in a research report on Monday, January 9th. Jefferies Group LLC reissued a “buy” rating and issued a $186.00 price target on shares of UnitedHealth Group in a research report on Tuesday, January 10th. Finally, Argus reissued a “buy” rating and issued a $170.00 price target on shares of UnitedHealth Group in a research report on Monday, January 23rd. Two analysts have rated the stock with a hold rating and twenty-two have given a buy rating to the stock. UnitedHealth Group presently has a consensus rating of “Buy” and an average price target of $182.65.

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

Shares of UnitedHealth Group (NYSE:UNH) traded up 0.66% on Friday, hitting $172.59. 3,877,349 shares of the company’s stock were exchanged. UnitedHealth Group has a 12-month low of $130.01 and a 12-month high of $176.14. The stock has a market cap of $166.32 billion, a price-to-earnings ratio of 22.09 and a beta of 0.68. The company’s 50-day moving average price is $170.26 and its 200 day moving average price is $162.54.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, April 18th. The healthcare conglomerate reported $2.37 EPS for the quarter, beating analysts’ consensus estimates of $2.17 by $0.20. UnitedHealth Group had a net margin of 3.92% and a return on equity of 21.20%. The company had revenue of $48.72 billion during the quarter, compared to analyst estimates of $48.21 billion. During the same period in the prior year, the firm earned $1.81 earnings per share. The business’s quarterly revenue was up 9.4% on a year-over-year basis. On average, equities analysts predict that UnitedHealth Group will post $9.79 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: “Cantor Fitzgerald Reiterates Overweight Rating for UnitedHealth Group Inc (UNH)” was first reported by Community Financial News and is owned by of Community Financial News. If you are reading this story on another domain, it was copied illegally and reposted in violation of US & international copyright & trademark law. The correct version of this story can be read at https://www.com-unik.info/2017/05/21/unitedhealth-group-inc-unh-stock-rating-reaffirmed-by-cantor-fitzgerald-updated-updated-updated.html.

In other news, Director Michele J. Hooper sold 15,000 shares of the business’s stock in a transaction dated Thursday, March 16th. The stock was sold at an average price of $170.89, for a total transaction of $2,563,350.00. Following the completion of the transaction, the director now directly owns 35,941 shares in the company, valued at approximately $6,141,957.49. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Kenneth Irwin Shine sold 838 shares of the business’s stock in a transaction dated Wednesday, April 19th. The stock was sold at an average price of $169.12, for a total value of $141,722.56. Following the transaction, the director now owns 28,528 shares of the company’s stock, valued at $4,824,655.36. The disclosure for this sale can be found here. Over the last quarter, insiders sold 40,148 shares of company stock valued at $6,806,849. Corporate insiders own 1.65% of the company’s stock.

Institutional investors have recently modified their holdings of the stock. Jackson Grant Investment Advisers Inc. raised its position in shares of UnitedHealth Group by 0.4% in the fourth quarter. Jackson Grant Investment Advisers Inc. now owns 1,093 shares of the healthcare conglomerate’s stock valued at $175,000 after buying an additional 4 shares in the last quarter. Biegel & Waller LLC raised its position in shares of UnitedHealth Group by 0.3% in the first quarter. Biegel & Waller LLC now owns 1,234 shares of the healthcare conglomerate’s stock valued at $202,000 after buying an additional 4 shares in the last quarter. Adirondack Trust Co. boosted its stake in UnitedHealth Group by 0.5% in the first quarter. Adirondack Trust Co. now owns 990 shares of the healthcare conglomerate’s stock valued at $162,000 after buying an additional 5 shares during the last quarter. Beck Mack & Oliver LLC boosted its stake in UnitedHealth Group by 0.3% in the third quarter. Beck Mack & Oliver LLC now owns 2,708 shares of the healthcare conglomerate’s stock valued at $379,000 after buying an additional 8 shares during the last quarter. Finally, Paradigm Financial Advisors LLC boosted its stake in UnitedHealth Group by 0.4% in the first quarter. Paradigm Financial Advisors LLC now owns 2,761 shares of the healthcare conglomerate’s stock valued at $452,000 after buying an additional 11 shares during the last quarter. Institutional investors and hedge funds own 86.67% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

12 Month Chart for NYSE:UNH

What are top analysts saying about UnitedHealth Group Inc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for UnitedHealth Group Inc and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit